清肺化痰汤治疗重症缺血性脑梗死合并卒中相关性肺炎患者临床效果观察研究
Clinical Study on the Efficacy of Qingfei Huatan Decoction in Treating Severe Ischemic Stroke Patients with Stroke-Associated Pneumonia
DOI: 10.12677/acm.2024.1472155, PDF,    科研立项经费支持
作者: 吴孝文, 李鹏翔*:海南医科大学第二附属医院神经内科,海南 海口
关键词: 重症脑梗死卒中相关性肺炎清肺化痰汤疗效观察Severe Ischemic Stroke Stroke-Associated Pneumonia Qingfei Huatan Decoction Efficacy Observation
摘要: 目的:研究清肺化痰汤治疗重症缺血性脑梗死合并卒中相关性肺炎患者临床效果观察研究。方法:选取2021.01~2022.12.31在海南医学院第二附属医院神经内科重症监护室收治的120名重症缺血性脑梗死合并卒中相关性肺炎患者相关临床资料,常规治疗组包含60例患者(对照组),在常规治疗上加用清肺化痰汤治疗患者60例(观察组),比较两组患者在经过1周治疗后的NIHSS评分、CPIS评分PCT、CRP变化。结果:两组经过治疗后,NIHSS评分及CPIS评分均较前下降,观察组CPIS评分下降更明显,差异有统计学意义(P < 0.05)。两组PCT及CRP均较治疗前下降,观察组PCT下降较对照组明显,差异有统计学意义(P < 0.05)。结论:清肺化痰汤用于重症缺血性脑梗死合并卒中相关性肺炎患者疗效可靠,对患者的预后有一定的帮助,有一定的临床应用价值,值得临床推广使用。
Abstract: Objective: This study aims to explore the clinical effectiveness of Qingfei Huatan Decoction in managing patients with severe ischemic cerebral infarction complicated by stroke-associated pneumonia. Methods: The clinical data of 120 severe ischemic cerebral infarction patients with stroke-associated pneumonia admitted to the neurological intensive care unit of the Second Affiliated Hospital of Hainan Medical University from January 2021 to December 2022 were selected. Sixty patients received conventional treatment (control group), while another 60 patients received Qingfei Huatan Decoction in addition to conventional treatment (observation group). The NIHSS scores, CPIS scores, PCT, and CRP changes were compared between the two groups after 1 week of treatment. Results: After the treatment, both NIHSS and CPIS scores decreased in both groups. However, the CPIS scores in the observation group showed a more significant reduction, indicating a statistically significant difference (P < 0.05). Additionally, PCT and CRP levels in both groups decreased compared to pre-treatment values, with a more notable decline in PCT in the observation group, also exhibiting a statistically significant difference (P < 0.05). Conclusion: Qingfei Huatan Decoction has demonstrated reliable therapeutic efficacy in treating patients with severe ischemic cerebral infarction complicated by stroke-associated pneumonia, providing valuable assistance to patients’ recovery prognosis. Therefore, it holds significant clinical application value and merits further promotion and utilization in clinical practice.
文章引用:吴孝文, 李鹏翔. 清肺化痰汤治疗重症缺血性脑梗死合并卒中相关性肺炎患者临床效果观察研究[J]. 临床医学进展, 2024, 14(7): 1360-1364. https://doi.org/10.12677/acm.2024.1472155

参考文献

[1] Lee, S.-H., Kim, B.J., Ryu, W.-S., Kim, C.K., Kim, N., Park, B.-J., et al. (2010) White Matter Lesions and Poor Outcome after Intracerebral Hemorrhage. Neurology, 74, 1502-1510. [Google Scholar] [CrossRef] [PubMed]
[2] Hilker, R., Poetter, C., Findeisen, N., Sobesky, J., Jacobs, A., Neveling, M., et al. (2003) Nosocomial Pneumonia after Acute Stroke. Stroke, 34, 975-981. [Google Scholar] [CrossRef] [PubMed]
[3] Katzan, I.L., Cebul, R.D., Husak, S.H., Dawson, N.V. and Baker, D.W. (2003) The Effect of Pneumonia on Mortality among Patients Hospitalized for Acute Stroke. Neurology, 60, 620-625. [Google Scholar] [CrossRef] [PubMed]
[4] Yu, Y., Weng, W., Su, F., Peng, T., Chien, Y., Wu, C., et al. (2016) Association between Pneumonia in Acute Stroke Stage and 3-Year Mortality in Patients with Acute First-Ever Ischemic Stroke. Journal of Clinical Neuroscience, 33, 124-128. [Google Scholar] [CrossRef] [PubMed]
[5] 韩杰. 神经科重症监护病房卒中相关性肺炎的危险因素分析[J]. 临床神经病学杂志, 2011, 24(2): 145-147.
[6] 宋苹, 张溪, 姚怀国. 卒中相关性肺炎的中医症状及证型特征[J]. 实用医学杂志, 2018, 34(9): 1557-1560.
[7] 向茜, 熊昕. 苇茎汤合麻杏石甘汤加减治疗卒中相关性肺炎痰热蕴肺证疗效及对患者外周血T淋巴细胞亚群、血清炎症因子的影响[J]. 中国实验方剂学杂志, 2018, 24(4): 180-184.
[8] 刘琳, 王珩, 刘涛, 等. 大柴胡汤对老年急性缺血性脑卒中患者卒中相关性肺炎的临床疗效观察[J]. 中国中西医结合急救杂志, 2018, 25(3): 264-267.
[9] 刘国成, 卢昌均, 韦冰心, 等. 培土生金法治疗卒中相关性肺炎的临床研究[J]. 世界中医药, 2016, 11(B3): 931-932.
[10] 胡亚梅, 李书剑, 李刚, 等. 重症脑血管病患者肺部感染病死率的影响因素分析[J]. 中华医院感染学杂志, 2014, 24(13): 3243-3244.
[11] 王拥军, 陈玉国, 吕传柱, 等. 卒中相关性肺炎诊治中国专家共识(2019更新版) [J]. 中国卒中杂志, 2019, 14(12): 1251-1262.
[12] 邓锦清, 刘泽, 郭振辉. 纤维支气管镜吸痰治疗在老年人吸入性肺炎中的应用[J]. 实用医学杂志, 2016, 32(3): 415-417.
[13] Muller, B. (2001) Ubiquitous Expression of the Calcitonin-I Gene in Multiple Tissues in Response to Sepsis. Journal of Clinical Endocrinology & Metabolism, 86, 396-404. [Google Scholar] [CrossRef] [PubMed]
[14] Fluri, F., Morgenthaler, N.G., Mueller, B., Christ-Crain, M. and Katan, M. (2012) Copeptin, Procalcitonin and Routine Inflammatory Markers-Predictors of Infection after Stroke. PLOS ONE, 7, e48309. [Google Scholar] [CrossRef] [PubMed]
[15] 高阜宏, 乔世岩, 黎明新. 感染性疾病中血清降钙素原和C反应蛋白检测的临床意义[J]. 实用医技杂志, 2006, 13(21): 3749-3750.
[16] 陈斯宁, 徐贞, 黄美杏. 清肺化痰汤对COPD急性加重期痰热郁肺症患者细胞因子的影响[J]. 云南中医中药杂志, 2008, 29(9): 6-7.
[17] 黄美杏, 龚享文, 陈斯宁, 等. 清肺化痰汤合红霉素对COPD痰热阻肺证大鼠模型的疗效及机理探讨[J]. 深圳中西医结合杂志, 2009, 19(1): 8-12.
[18] 陈斯宁, 韦思尊, 谭玉萍, 等. 清肺化痰汤配合西药对慢性阻塞性肺疾病氧化/抗氧化失衡的影响[J]. 四川中医, 2012, 30(7): 70-71.
[19] 陆彩云, 陈斯宁, 杨红梅, 等. 自拟清肺化痰汤治疗痰热郁肺证COPD急性加重期临床观察[J]. 广西中医药, 2016, 39(3): 18-20.